<code id='43748910DA'></code><style id='43748910DA'></style>
    • <acronym id='43748910DA'></acronym>
      <center id='43748910DA'><center id='43748910DA'><tfoot id='43748910DA'></tfoot></center><abbr id='43748910DA'><dir id='43748910DA'><tfoot id='43748910DA'></tfoot><noframes id='43748910DA'>

    • <optgroup id='43748910DA'><strike id='43748910DA'><sup id='43748910DA'></sup></strike><code id='43748910DA'></code></optgroup>
        1. <b id='43748910DA'><label id='43748910DA'><select id='43748910DA'><dt id='43748910DA'><span id='43748910DA'></span></dt></select></label></b><u id='43748910DA'></u>
          <i id='43748910DA'><strike id='43748910DA'><tt id='43748910DA'><pre id='43748910DA'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:26
          a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT
          Adobe

          In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

          It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

          advertisement

          The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          FDA approves RSV monoclonal antibody for infants, toddlers
          FDA approves RSV monoclonal antibody for infants, toddlers

          SanofiTheFoodandDrugAdministrationapprovedamonoclonalantibodytoprotectinfantsandyoungchildrenfromsev

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Startup Neumora takes a novel depression drug to Phase 3

          AdobeNeumora,aprivatelyheldbiotechcompany,ismovingintothefinalphaseoftestingwithanoveltreatmentforde